Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting
Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · Jan 24, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a pharmacist-led program can help patients who have health-related social needs when they are transitioning from the hospital to home. The program includes screening patients in the emergency department using a specific tool to identify these needs, connecting them to local community organizations that can help, and following up with them afterward to see how things are going. The trial will involve 150 patients, with half receiving this support and the other half not, allowing researchers to compare results regarding hospital visits and readmissions.
To be eligible for this study, patients must be at least 18 years old and be treated at Buffalo General Medical Center, with plans to go home after their visit. However, those who have cognitive impairments that prevent them from giving consent or who do not speak English will not be included. Participants can expect to receive personalized assistance aimed at addressing their health-related needs, which may lead to better health outcomes and fewer hospital visits in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: Patients must be at least 18 years old.
- • Status: Patients being seen at Buffalo General Medical Center (BGMC).
- • Discharge Plan: It is anticipated that the patient will be discharged home. Control Group: Patients in the control group will meet the same inclusion criteria as those in the intervention group, except they will not receive the health-related social needs (HRSN) screening.
- Exclusion Criteria:
- • Cognitive Impairment: Patients who are cognitively impaired and unable to consent will be excluded.
- • Non-English Speakers: Non-English speaking individuals are excluded due to the nature of the intervention requiring direct communication between the clinical pharmacist and participants
About State University Of New York At Buffalo
The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buffalo, New York, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported